Hybrid DenseNet-U-Net framework for automated grading of renal cell carcinoma

• by Rohini Jadhav, Banani Mohapatra, Bhavnish Walia, Sital Dash, Kailas Patil, Shrikant Jadhav, Ishwari Rohit Raskar

• May 16, 2026

Correction to: HLA Class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC

• by Jie Mei, Guanyu Jiang, Yundi Chen, Yongrui Xu, Yuan Wan, Ruo Chen, Feng Liu, Wenjun Mao, Mingfeng Zheng, Junying Xu

• September 17, 2026

Dana-Farber/Boston Children's Named the Top Pediatric Cancer Program in the Nation for 2026-2027

U.S. News & World Report has recognized Dana-Farber/Boston Children’s Cancer and Blood Disorders Center as the #1 pediatric cancer program in the nation in its 2026-2027 Best Children’s Hospitals report.

• by

• September 15, 2026

• 3 min

Clinician Counseling and Weight Loss Attempts Among Survivors of Obesity-Associated Cancers

• by Ryan Howard, Archana Radhakrishnan, Dina H. Griauzde, Jennifer J. Griggs, Lesly A. Dossett

• September 9, 2026